Quarterly Results

ARVIND REMEDIES LTD.

NSE : NABSE : 531823ISIN CODE : INE211C01037Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.700 (0 %)
PREV CLOSE ( ) 4.70
OPEN PRICE ( ) 4.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2850
TODAY'S LOW / HIGH ( )4.70 4.70
52 WK LOW / HIGH ( ) 4.74.7
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Jun 2016
Mar 2016
Dec 2015
Sep 2015
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
14.54
24.59
20.41
62.96
Total Expenditure
17.65
979.34
20.18
56.8
PBIDT (Excl OI)
-3.11
-954.75
0.23
6.16
Other Income
7.25
35.31
NA
NA
Operating Profit
4.14
-919.44
0.17
6.16
Interest
NA
0.01
2.17
8.02
Exceptional Items
-204.53
NA
0.00
0.00
PBDT
-200.39
-919.46
-2
-1.86
Depreciation
60
71.99
58.93
58.93
Profit Before Tax
-260.39
-991.45
-60.93
-60.79
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-260.39
-991.45
-60.93
-60.79
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-260.39
-991.45
-60.93
-60.79
Equity Capital
681.26
681.26
681.26
681.26
Face Value (IN RS)
10
10
10
10
Reserves
-2217.23
Calculated EPS
-3.82
-14.55
-0.89
-0.89
Calculated EPS (Annualised)
-15.28
-58.21
-3.57
-3.56
No of Public Share Holdings
65690444
65690444
NA
65690444
% of Public Share Holdings
96.42
96.42
NA
96.42
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-21.38
-3882.67
1.12
9.78
PBIDTM%
28.47
-3739.08
0.83
9.78
PBDTM%
-1378.19
-3739.16
-9.79
-2.95
PBTM%
-1790.85
-4031.92
-298.53
-96.55
PATM%
-1790.85
-4031.92
-298.53
-96.55
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.